BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 23873329)

  • 1. Characteristics of cerebrovascular accidents at time of diagnosis in a series of 98 patients with giant cell arteritis.
    Zenone T; Puget M
    Rheumatol Int; 2013 Dec; 33(12):3017-23. PubMed ID: 23873329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extra- and intracranial cerebral vasculitis in giant cell arteritis: an observational study.
    Larivière D; Sacre K; Klein I; Hyafil F; Choudat L; Chauveheid MP; Papo T
    Medicine (Baltimore); 2014 Dec; 93(28):e265. PubMed ID: 25526454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical, laboratory, radiological features, and outcome in 26 patients with aortic involvement amongst a case series of 63 patients with giant cell arteritis].
    Daumas A; Rossi P; Bernard-Guervilly F; Francès Y; Berbis J; Durand JM; Kaplanski G; Ebbo M; Harlé JR; Weiller PJ; Serratrice J; Disdier P; Gayet S; Villani P; Granel B
    Rev Med Interne; 2014 Jan; 35(1):4-15. PubMed ID: 23906779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of cerebrovascular accidents in giant cell arteritis in a defined population.
    Pego-Reigosa R; Garcia-Porrua C; Piñeiro A; Dierssen T; Llorca J; Gonzalez-Gay MA
    Clin Exp Rheumatol; 2004; 22(6 Suppl 36):S13-7. PubMed ID: 15675128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stroke and multi-infarct dementia as presenting symptoms of giant cell arteritis: report of 7 cases and review of the literature.
    Solans-Laqué R; Bosch-Gil JA; Molina-Catenario CA; Ortega-Aznar A; Alvarez-Sabin J; Vilardell-Tarres M
    Medicine (Baltimore); 2008 Nov; 87(6):335-344. PubMed ID: 19011505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reversibility of vertebrobasilar stenoses following treatment with corticosteroid therapy in patients with giant cell arteritis].
    Polomat K; Chausson N; Olindo S; Smadja D
    Rev Neurol (Paris); 2010 Nov; 166(11):940-3. PubMed ID: 20400168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pericardial effusion and giant cell arteritis.
    Zenone T; Puget M
    Rheumatol Int; 2014 Oct; 34(10):1465-9. PubMed ID: 24531736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strokes at time of disease diagnosis in a series of 287 patients with biopsy-proven giant cell arteritis.
    Gonzalez-Gay MA; Vazquez-Rodriguez TR; Gomez-Acebo I; Pego-Reigosa R; Lopez-Diaz MJ; Vazquez-Triñanes MC; Miranda-Filloy JA; Blanco R; Dierssen T; Gonzalez-Juanatey C; Llorca J
    Medicine (Baltimore); 2009 Jul; 88(4):227-235. PubMed ID: 19593228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe Intracranial Involvement in Giant Cell Arteritis: 5 Cases and Literature Review.
    Alsolaimani RS; Bhavsar SV; Khalidi NA; Pagnoux C; Mandzia JL; Tay K; Barra LJ
    J Rheumatol; 2016 Mar; 43(3):648-56. PubMed ID: 26773119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Giant Cell Arteritis-related Stroke: A Retrospective Multicenter Case-control Study.
    de Boysson H; Liozon E; Larivière D; Samson M; Parienti JJ; Boutemy J; Maigné G; Martin Silva N; Ly K; Touzé E; Bonnotte B; Aouba A; Sacré K; Bienvenu B
    J Rheumatol; 2017 Mar; 44(3):297-303. PubMed ID: 28089985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Temporal arteritis and cerebrovascular complications].
    Øverlie H; Kerty E
    Tidsskr Nor Laegeforen; 2005 Nov; 125(21):2936-8. PubMed ID: 16276375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral vertebral artery occlusion without stroke secondary to giant cell arteritis.
    Bajko Z; Filep RC; Maier S; Motataianu A; Andone S; Balasa R
    Acta Reumatol Port; 2019 Sep; 44(3):270-272. PubMed ID: 31575840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic value of clinical signs in giant cell arteritis: analysis of 415 temporal artery biopsy findings].
    Strady C; Arav E; Strady A; Jaussaud R; Beguinot I; Rouger C; Pluot M; Remy G
    Ann Med Interne (Paris); 2002 Feb; 153(1):3-12. PubMed ID: 11994684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Giant cell arteritis: diagnostic accuracy of MR imaging of superficial cranial arteries in initial diagnosis-results from a multicenter trial.
    Klink T; Geiger J; Both M; Ness T; Heinzelmann S; Reinhard M; Holl-Ulrich K; Duwendag D; Vaith P; Bley TA
    Radiology; 2014 Dec; 273(3):844-52. PubMed ID: 25102371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-T MRI detects inflammatory stenosis of the vertebral artery in giant cell arteritis.
    Geiger J; Uhl M; Peter HH; Langer M; Bley TA
    Clin Rheumatol; 2008 May; 27(5):663-6. PubMed ID: 18172573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dry cough is a frequent manifestation of giant cell arteritis.
    Zenone T; Puget M
    Rheumatol Int; 2013 Aug; 33(8):2165-8. PubMed ID: 22451028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Giant cell arteritis as a cause of first-ever stroke.
    Wiszniewska M; Devuyst G; Bogousslavsky J
    Cerebrovasc Dis; 2007; 24(2-3):226-30. PubMed ID: 17630482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vertebral artery halo sign in patients with stroke: a key clue for the prompt diagnosis of giant cell arteritis.
    García-García J; Ayo-Martín Ó; Argandoña-Palacios L; Segura T
    Stroke; 2011 Nov; 42(11):3287-90. PubMed ID: 21940968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrovascular events are associated with lower survival in giant cell arteritis: A case-controlled multicenter study.
    Chazal T; Couture P; Rosso C; Haroche J; Léger A; Hervier B; Deltour S; Rufat P; Amoura Z; Cohen Aubart F
    Joint Bone Spine; 2018 May; 85(3):383-385. PubMed ID: 28532822
    [No Abstract]   [Full Text] [Related]  

  • 20. Diffusion MR imaging of the optic nerve in a patient with giant-cell arteritis and vertebral artery vasculitis.
    Biotti D; Savatovski J; Bidot S; Shotar E; Charbonneau F; Obadia M; Gueguen A
    Eur Neurol; 2011; 66(2):83-4. PubMed ID: 21778731
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.